Takahiro Hirayama
Okayama University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Takahiro Hirayama.
Journal of intensive care | 2017
Takahiro Hirayama; Nobuyuki Nosaka; Yasumasa Okawa; Soichiro Ushio; Yoshihisa Kitamura; Toshiaki Sendo; Toyomu Ugawa; Atsunori Nakao
BackgroundIn Japan, nafamostat mesylate (NM) is frequently used as an anticoagulant during continuous renal replacement therapy (CRRT). The dialyzer membrane AN69ST has been reported to adsorb NM and affect the management of anticoagulant therapy. However, the adsorbed amount has not yet been quantitatively assessed. Therefore, in this study, we evaluated the pre- and post-hemofilter prolongation of the activated clotting time (ACT) in patients with AN69ST and PS membranes. We also measured the adsorption of NM in three types of CRRT membranes using an experimental model.MethodsIn a study of patients who underwent CRRT using AN69ST or PS membranes in 2015 at the Advanced Emergency and Critical Care Center, Okayama University Hospital, pre- and post-hemofilter ACT measurements were extracted retrospectively, and the difference was calculated. In addition, AN69ST (sepXiris100), PS (HEMOFEEL SHG-1.0), and PMMA membranes (HEMOFEEL CH-1.0N) were used in an in vitro model of a dialysis circuit, and the concentrations of NM were measured in pre- and post-hemofilter membranes and filtrates.ResultsThe ACT difference was significantly lower in the group using AN69ST membranes (p < 0.01). In the in vitro model (n = 4) with adsorption and filtration, the post-hemofilter and filtrate concentrations of NM in AN69ST membranes were significantly lower than those in the PS and PMMA membranes (p < 0.01). The NM adsorption clearance of the AN69ST membrane was significantly higher than that of the PS and PMMA membranes.ConclusionsThe AN69ST membrane had higher NM adsorption than the PS and PMMA membranes. This may have resulted in the lower ACT difference in patients undergoing CRRT using the AN69ST membrane than in patients undergoing CRRT using PS or PMMA membranes.
Internal Medicine | 2015
Hideharu Hagiya; Takahiro Hirayama; Toyomu Ugawa; Fumio Otsuka
A 19-year-old Japanese woman presented with a suddenonset of difficulty in opening her mouth (Picture A). Trismus and cervicofacial involuntary movements in the patient were easily triggered by stimulation. Although there was no recent history of trauma, minor skin disorders were seen on her foot (Picture B). The patient’s medical history revealed that she had never been vaccinated with tetanus toxoid. We diagnosed the patient with tetanus and administered tetanus immune globulin (5,000 units), toxoid vaccination, and intravenous penicillin G (2,400 million units per day). The patient’s neuromuscular manifestations gradually improved and she was discharged on day 10. Tetanus is a fatal disease in developing countries where vaccination is unavailable. In Japan, with the introduction of preventive immunization in 1968, the incidence of tetanus has dramatically declined. Presently, almost all Japanese cases are in patients over forty years of age who had been born before the implementation of routine vaccination; teenagers are scarcely reported as having this disease (1). For cases in which tetanus is suspected, urgent treatment is necessary (2).
Intensive Care Medicine Experimental | 2015
Nao Umei; I Shingo; Yoshihito Ujike; Tetsuya Yumoto; A Ida; Takahiro Hirayama; Naoki Shiba; Kohei Tsukahara; Yo Kinami; Michihisa Terado; Hideo Yamanouchi; Keiji Sato; Toyomu Ugawa
Intr Several studies have investigated the factors associated with the return of spontaneous circulation (ROSC) in outof-hospital cardiac arrest (OHCA) cases. The most analyzed factor is pre-hospital resuscitation, such as an early phone call for the ambulance, bystander cardiopulmonary resuscitation (CPR), presentation with ventricular fibrillation, and medication. The blood gas parameters have not yet been reported as a predictive factor for ROSC.
Journal of intensive care | 2014
Tetsuya Yumoto; Atsuyoshi Iida; Takahiro Hirayama; Kohei Tsukahara; Naoki Shiba; Hideo Yamanouchi; Keiji Sato; Toyomu Ugawa; Shingo Ichiba; Yoshihito Ujike
Acta Medica Okayama | 2014
Takahiro Hirayama; Osamu Nagano; Naoki Shiba; Tetsuya Yumoto; Keiji Sato; Michihisa Terado; Toyomu Ugawa; Shingo Ichiba; Yoshihito Ujike
Critical Care | 2014
Tetsuya Yumoto; Atsuyoshi Iida; Emily Knaup; Nobuyuki Nosaka; Sunao Morisada; Takahiro Hirayama; Naoki Shiba; Kohei Tsukahara; H Nosaka; Y Kinami; Michihisa Terado; Hideo Yamanouchi; Keiji Sato; Toyomu Ugawa; Shingo Ichiba; Yoshihito Ujike
Acta Medica Okayama | 2018
Chika Tsuboi; Hiromichi Naito; Shingo Hagioka; Hiroaki Hanafusa; Takahiro Hirayama; Yoshinori Kosaki; Atsuyoshi Iida; Tetsuya Yumoto; Kohei Tsukahara; Naoki Morimoto; Atsunori Nakao
Medical Case Reports | 2016
Michihisa Terado; Atsuyoshi Iida; Kohei Tsukahara; Keiji Sato; Masami Takagaki; Takahiro Hirayama; Atsunori Nakao
Critical Care | 2015
Takahiro Hirayama; Shingo Ichiba; Keiji Sato; Tetsuya Yumoto; Kohei Tsukahara; Michihisa Terado; U Yoshihito; Toyomu Ugawa
Critical Care | 2015
S Namba; K Hayashi; Takahiro Hirayama; Y Namba; Michihisa Terado; P Easton; Yoshihito Ujike